Market open
Enovis Corporation/$ENOV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Ticker
$ENOV
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
7,367
Website
ENOV Metrics
BasicAdvanced
$2.1B
-
-$14.93
2.03
-
Price and volume
Market cap
$2.1B
Beta
2.03
52-week high
$49.38
52-week low
$35.14
Average daily volume
826K
Financial strength
Current ratio
2.167
Quick ratio
0.86
Long term debt to equity
53.111
Total debt to equity
54.763
Interest coverage (TTM)
-0.59%
Management effectiveness
Return on assets (TTM)
0.73%
Return on equity (TTM)
-27.65%
Valuation
Price to revenue (TTM)
0.967
Price to book
0.8
Price to tangible book (TTM)
-4.6
Price to free cash flow (TTM)
-30.31
Growth
Revenue change (TTM)
23.46%
Earnings per share change (TTM)
2,337.40%
3-year revenue growth (CAGR)
13.90%
3-year earnings per share growth (CAGR)
120.07%
ENOV News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Enovis Corporation stock?
Enovis Corporation (ENOV) has a market cap of $2.1B as of March 12, 2025.
What is the P/E ratio for Enovis Corporation stock?
The price to earnings (P/E) ratio for Enovis Corporation (ENOV) stock is 0 as of March 12, 2025.
Does Enovis Corporation stock pay dividends?
No, Enovis Corporation (ENOV) stock does not pay dividends to its shareholders as of March 12, 2025.
When is the next Enovis Corporation dividend payment date?
Enovis Corporation (ENOV) stock does not pay dividends to its shareholders.
What is the beta indicator for Enovis Corporation?
Enovis Corporation (ENOV) has a beta rating of 2.03. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.